Back | Next |
home / stock / lgvn / lgvn message board
Subject | By | Source | When |
---|---|---|---|
$LGVN just the news we needed | TheFinalCD | investorshub | 04/17/2023 2:18:21 PM |
here we go bulls news is here | TheFinalCD | investorshub | 04/17/2023 1:00:58 PM |
just the news we needed | Sibware | investorshub | 04/16/2023 11:13:57 PM |
must see | dennisv | investorshub | 04/16/2023 12:06:59 PM |
Have a look at this | dinogreeves | investorshub | 04/15/2023 10:12:49 AM |
Price gaining last trade up | Marvy | investorshub | 04/14/2023 8:03:58 AM |
$LGVN Good news recently, we should start to see this one move | Roadtojourney | investorshub | 04/13/2023 5:02:11 AM |
$LGVN MomentumIts gaining | dennisv | investorshub | 04/12/2023 11:59:59 AM |
Anyone hear anything lately? Want to see this one go | Roadtojourney | investorshub | 04/09/2023 1:11:51 AM |
$LGVN 5000 shares holding for 2x at least | heyitsmeagain | investorshub | 10/27/2022 2:42:04 PM |
Looking for $5 | heyitsmeagain | investorshub | 10/26/2022 10:24:40 PM |
Load up! Gonna fly | heyitsmeagain | investorshub | 10/26/2022 3:32:40 PM |
Insiders are selling great sign of a good | help me | investorshub | 10/05/2022 11:19:14 PM |
After hours just took off last 5 minutes | vhgier | investorshub | 09/28/2022 12:12:03 AM |
U.S. Food and Drug Administration (FDA) Grants Fast | subslover | investorshub | 08/31/2022 12:32:29 PM |
https://finance.yahoo.com/news/longeveron-receives-intent-grant-notice-120000981 | Anite | investorshub | 08/25/2022 1:58:56 PM |
Makes no sense, whats wrong with you pos | Roadtojourney | investorshub | 06/07/2022 8:01:48 PM |
It looks like this little piggy stayed home. | pinkslipjunkie | investorshub | 06/02/2022 3:12:40 PM |
Common man atleast go with the market pos?? | Roadtojourney | investorshub | 05/27/2022 5:42:20 PM |
Common most of pos stocks doubled 1 more | Roadtojourney | investorshub | 05/16/2022 4:12:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Longeveron Inc. Company Name:
LGVN Stock Symbol:
NASDAQ Market:
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be releasing its fi...
MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S. fina...
Longeveron (NASDAQ: LGVN) , a clinical-stage, biotechnology company developing regenerative medicines, is one of 96 companies slated to participate at the Planet MicroCap Showcase: VEGAS. The three-day event begins in Las Vegas tomorrow and runs through May 2, 2024. The event kicks off with ...